Month | Enrollment | Data collection | ||||
---|---|---|---|---|---|---|
0 | 3 ± 1 | 6 ± 1 | 9 ± 1 | / | 12 ± 1 | |
Visit | V0 | TC1 | TC2 | TC3 | UC | V1 |
Informed consent | X | |||||
Inclusion/exclusion criteria | X | |||||
Demography (date of birth, ethnicity, gender, education, marital status, socioeconomic status, insurance status, residence area, occupation) | X | |||||
Physical examination | X | X | ||||
Smoking history | X | |||||
COPD history | X | |||||
Disease severity GOLD 2016 | X | X | ||||
Comorbidities, other respiratory diseases | X | X | X | X | X | X |
Exacerbations | X | X | X | X | X | X |
Symptoms | X | X | X | X | X | X |
Spirometry and bronchial dilation if available | X | X | X | |||
CAT, mMRC | X | X | X | X | X | |
COPD-Q | X | X | ||||
FENO if available | X | X | X | |||
Chest CT imaging if available | X | X | X | |||
Induced sputum test if available | X | X | X | |||
Lab tests (blood gases, C-reactive protein and hematology) if available | X | X | X | |||
COPD medications | X | X | X | X | X | X |
COPD non-pharmacological treatment | X | X | X | X | X | X |
Total COPD treatment expenses | X | X | X | X | X | X |